HomeMBX • NASDAQ
add
MBX Biosciences Inc
Previous close
$13.21
Day range
$13.04 - $15.15
Year range
$4.81 - $26.19
Market cap
494.33M USD
Avg Volume
460.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.80M | 30.90% |
Net income | -19.41M | -22.41% |
Net profit margin | — | — |
Earnings per share | -0.58 | — |
EBITDA | -21.74M | -31.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 224.91M | 306.98% |
Total assets | 231.52M | 268.18% |
Total liabilities | 12.28M | 46.05% |
Total equity | 219.24M | — |
Shares outstanding | 33.59M | — |
Price to book | 2.02 | — |
Return on assets | -22.83% | — |
Return on capital | -23.94% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -19.41M | -22.41% |
Cash from operations | -17.43M | -31.38% |
Cash from investing | 25.99M | 429.31% |
Cash from financing | 1.33M | 175.30% |
Net change in cash | 9.88M | 143.09% |
Free cash flow | -11.86M | -38.89% |
About
Founded
2018
Headquarters
Website
Employees
43
